Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06503341
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-09
Brief Title:
A Hospital-Based Registry of Preventive Cardiology Clinics
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PREVENT-CARD
Brief Summary:
More research is needed to articulate the most effective ways to use these tools as screening tests in cardiovascular risk assessments and how they ultimately affect CVD mortality and morbidity outcomes Clinicians are encouraged to continue sharing decision-making with patients to combine their unique cardiovascular risk factors and develop a comprehensive effective treatment plan
Detailed Description:
Study Design observational study Duration of Study ongoing Sample Size All patients presenting to preventive cardiology clinics at the National Institute of Cardiovascular Diseases NICVD Karachi Pakistan
Sampling Technique Non-probability consecutive sampling Data Collection Procedure Verbal informed consent will be obtained from all the patients regarding their participation in the study and publication of study findings while maintaining confidentiality Consecutive patients presenting preventive cardiology clinics at the National Institute of Cardiovascular Diseases NICVD Karachi Pakistan will be included in this registry Demographic characteristics physical examination clinical history risk modification lab assessment and ASCVD risk score at presentation and at every follow-up will be recorded using a structural questionnaire
Data Analysis Procedure The Tentative analysis plan uses collected data for research publications The statistical package for social sciences SPSS 21 will be used to analyze baseline characteristics The Shapiro-Wilk test will be applied to check the hypothesis of normality for quantitative continuous variables Descriptive statistics such as mean SD median IQR skewness maximum and minimum will be calculated for quantitative continuous variables Frequency and percentages will be calculated for categorical variables
Sampling Technique Non-probability consecutive sampling Data Collection Procedure Verbal informed consent will be obtained from all the patients regarding their participation in the study and publication of study findings while maintaining confidentiality Consecutive patients presenting preventive cardiology clinics at the National Institute of Cardiovascular Diseases NICVD Karachi Pakistan will be included in this registry Demographic characteristics physical examination clinical history risk modification lab assessment and ASCVD risk score at presentation and at every follow-up will be recorded using a structural questionnaire
Data Analysis Procedure The Tentative analysis plan uses collected data for research publications The statistical package for social sciences SPSS 21 will be used to analyze baseline characteristics The Shapiro-Wilk test will be applied to check the hypothesis of normality for quantitative continuous variables Descriptive statistics such as mean SD median IQR skewness maximum and minimum will be calculated for quantitative continuous variables Frequency and percentages will be calculated for categorical variables
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None